Phase I/II trial to compare two formulations of AMZ 0026 (AMZ 0026 and AMZ 0026H).
Phase of Trial: Phase I/II
Latest Information Update: 20 Mar 2012
At a glance
- Drugs AMZ 0026 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 20 Mar 2012 Planned number of patients changed to 32.
- 20 Mar 2012 New trial record